ATE364037T1 - Tryptasehemmer - Google Patents

Tryptasehemmer

Info

Publication number
ATE364037T1
ATE364037T1 AT02722086T AT02722086T ATE364037T1 AT E364037 T1 ATE364037 T1 AT E364037T1 AT 02722086 T AT02722086 T AT 02722086T AT 02722086 T AT02722086 T AT 02722086T AT E364037 T1 ATE364037 T1 AT E364037T1
Authority
AT
Austria
Prior art keywords
tryptase inhibitors
inhibitors
tryptase
compounds
formula
Prior art date
Application number
AT02722086T
Other languages
English (en)
Inventor
Thomas Martin
Thomas Baer
Josef Stadlwieser
Wolf-Ruediger Ulrich
Andreas Dominik
Daniela Bundschuh
Karl Zech
Christian Sommerhoff
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE364037T1 publication Critical patent/ATE364037T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT02722086T 2001-02-21 2002-02-16 Tryptasehemmer ATE364037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01104092 2001-02-21

Publications (1)

Publication Number Publication Date
ATE364037T1 true ATE364037T1 (de) 2007-06-15

Family

ID=8176546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722086T ATE364037T1 (de) 2001-02-21 2002-02-16 Tryptasehemmer

Country Status (9)

Country Link
US (1) US7101911B2 (de)
EP (1) EP1363874B1 (de)
JP (1) JP2004518735A (de)
AT (1) ATE364037T1 (de)
AU (1) AU2002253026B2 (de)
CA (1) CA2438711A1 (de)
DE (1) DE60220504T2 (de)
ES (1) ES2287268T3 (de)
WO (1) WO2002066420A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962941B2 (en) 2001-06-19 2005-11-08 Altana Pharma Ag Tryptase inhibitors
US20090069448A1 (en) 2005-05-09 2009-03-12 Akikazu Matsumoto Degradable polymer and process for production thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656660A (en) 1994-06-01 1997-08-12 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
SK37997A3 (en) * 1994-09-23 1998-12-02 Arris Pharm Corp Compositions and methods for treating mast-cell inflammatory condition
EP0934293A1 (de) * 1996-07-30 1999-08-11 Arris Pharmaceutical Corporation Verbindungen und präparate für eine behandelung von krankheiten die mit tryptaseaktivität zusammenhangen
AU8997498A (en) 1997-09-05 1999-03-29 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitor
WO1999024407A1 (en) 1997-11-10 1999-05-20 Array Biopharma, Inc. Compounds which inhibit tryptase activity
US6221914B1 (en) 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
ES2233025T3 (es) 1998-02-06 2005-06-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Agente inhibidores de la triptasa.
US6613769B1 (en) 1998-02-06 2003-09-02 Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V. Tryptase inhibitors
JP2003524598A (ja) 1998-09-04 2003-08-19 アルタナ ファルマ アクチエンゲゼルシャフト 新規ピラノセン
EP1208089B1 (de) 1999-08-10 2004-10-13 ALTANA Pharma AG Diazocindionderivate und ihre verwendung als tryptase inhibitoren
DE19937721A1 (de) 1999-08-10 2001-02-15 Max Planck Gesellschaft Neue Diketopiperazine
US6960588B1 (en) * 1999-09-14 2005-11-01 Altana Pharma Ag Tryptase inhibitors
CA2392127A1 (en) 1999-12-20 2001-06-28 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors
ES2222259T3 (es) 1999-12-20 2005-02-01 Altana Pharma Ag Inhibidores de triptasa.

Also Published As

Publication number Publication date
DE60220504D1 (en) 2007-07-19
CA2438711A1 (en) 2002-08-29
JP2004518735A (ja) 2004-06-24
US20040087791A1 (en) 2004-05-06
EP1363874B1 (de) 2007-06-06
WO2002066420A2 (en) 2002-08-29
EP1363874A2 (de) 2003-11-26
US7101911B2 (en) 2006-09-05
AU2002253026B2 (en) 2007-08-09
ES2287268T3 (es) 2007-12-16
WO2002066420A3 (en) 2003-02-27
DE60220504T2 (de) 2008-02-14

Similar Documents

Publication Publication Date Title
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
NO20041493L (no) Kjemiske forbindelser.
ATE275544T1 (de) Serinprotease-inhibitoren
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
SE0103710D0 (sv) Compounds
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
DE60202669D1 (de) 6-phenylbenzonaphthyidine
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DK1244643T3 (da) Tryptaseinhibitorer
MXPA06000372A (es) Compuestos de silicio y su uso.
DK1244614T3 (da) Tryptase-inhibitorer
ATE348803T1 (de) Tryptase-inhibitoren
ATE364037T1 (de) Tryptasehemmer
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
ATE349427T1 (de) Tryptaseinhibitoren
DE60120398D1 (de) Imidazopyridin-8-one
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
GB0205327D0 (en) compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties